Cargando…

PROTACs– a game-changing technology

INTRODUCTION: Proteolysis – targeting chimeras (PROTACs) have emerged as a new modality with the potential to revolutionize drug discovery. PROTACs are heterobifunctional molecules comprising of a ligand targeting a protein of interest, a ligand targeting an E3 ligase and a connecting linker. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konstantinidou, Markella, Li, Jingyao, Zhang, Bidong, Wang, Zefeng, Shaabani, Shabnam, Brake, Frans Ter, Essa, Khaled, Dömling, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008130/ https://www.ncbi.nlm.nih.gov/pubmed/31538491 http://dx.doi.org/10.1080/17460441.2019.1659242

Ejemplares similares

The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
por: Konstantinidou, Markella, et al.
Publicado: (2020)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
por: Shaabani, Shabnam, et al.
Publicado: (2022)

1,3,4-Oxadiazoles by Ugi-Tetrazole and Huisgen Reaction
por: Wang, Qian, et al.
Publicado: (2019)

The PROTAC technology in drug development
por: Zou, Yutian, et al.
Publicado: (2019)

Editorial: Isocyanide-Based Multicomponent Reactions
por: Rudick, Jonathan G., et al.
Publicado: (2020)

Highly Stereoselective Ugi/Pictet–Spengler Sequence
por: Zhang, Bidong, et al.
Publicado: (2022)

Pd-Catalyzed de Novo Assembly of Diversely Substituted Indole-Fused Polyheterocycles
por: Wang, Qian, et al.
Publicado: (2019)

Correction to Pd-Catalyzed de Novo Assembly of Diversely Substituted Indole-Fused Polyheterocycles
por: Wang, Qian, et al.
Publicado: (2020)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

Recent Advances of Degradation Technologies Based on PROTAC Mechanism
por: Xiao, Mingchao, et al.
Publicado: (2022)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022)

PROTAC-DB 2.0: an updated database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2022)

Automated, Accelerated Nanoscale Synthesis of Iminopyrrolidines
por: Osipyan, Angelina, et al.
Publicado: (2020)

‘Chemistry at the speed of sound’: automated 1536-well nanoscale synthesis of 16 scaffolds in parallel
por: Gao, Li, et al.
Publicado: (2023)

Correction: ‘Chemistry at the speed of sound’: automated 1536-well nanoscale synthesis of 16 scaffolds in parallel
por: Gao, Li, et al.
Publicado: (2023)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
por: Wu, Yanli, et al.
Publicado: (2022)

PROTACs in gastrointestinal cancers
por: Chen, Yu, et al.
Publicado: (2022)

DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)

Two-Step Macrocycle Synthesis by Classical Ugi Reaction
por: Abdelraheem, Eman M. M., et al.
Publicado: (2018)

Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
por: Pei, Haixiang, et al.
Publicado: (2019)

Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2022)

Multicomponent reaction–derived covalent inhibitor space
por: Sutanto, Fandi, et al.
Publicado: (2021)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

Ugi Multicomponent Reaction Based Synthesis of Medium-Sized Rings
por: Abdelraheem, Eman M. M., et al.
Publicado: (2017)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

PROTACs: The Future of Leukemia Therapeutics
por: Anwar, Zubair, et al.
Publicado: (2022)

PROTACs in the Management of Prostate Cancer
por: Yedla, Poornachandra, et al.
Publicado: (2023)

Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers
por: Gao, Kai, et al.
Publicado: (2021)

Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021)

Small-Molecule PROTACs for Cancer Immunotherapy
por: Liu, Zefan, et al.
Publicado: (2022)

Synthesis and Pharmacochemistry of New Pleiotropic Pyrrolyl Derivatives
por: Konstantinidou, Markella, et al.
Publicado: (2015)

Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020)

Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
por: Shao, Jingwei, et al.
Publicado: (2021)

Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader
por: Tovell, Hannah, et al.
Publicado: (2019)

Concise Synthesis of Tetrazole Macrocycle
por: Abdelraheem, Eman M. M., et al.
Publicado: (2017)

Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment
por: Rashidi, Fatma B., et al.
Publicado: (2018)

Correction: Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment
por: Rashidi, Fatma B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kvsup7oldg5crsfe9n6lslrq58